XML 28 R40.htm IDEA: XBRL DOCUMENT v2.4.0.6
Goodwill and Intangible Assets (Details) (USD $)
9 Months Ended
Sep. 30, 2012
Y
Sep. 30, 2011
Dec. 31, 2011
Goodwill and intangible assets information      
Change in goodwill due to foreign currency translation and other adjustments   $ 300,000,000  
Goodwill 15,708,924,000   15,705,380,000
Gross amount of amortizable intangible assets 17,600,000,000   17,500,000,000
Accumulated amortization of intangible assets 9,400,000,000   8,300,000,000
Indefinite-lived intangible assets related to in-process research and development acquired in a business combination 764,000,000   814,000,000
Estimated annual amortization expense, intangible assets, 2012 1,500,000,000    
Estimated annual amortization expense, intangible assets, 2013 1,300,000,000    
Estimated annual amortization expense, intangible assets, 2014 1,000,000,000    
Estimated annual amortization expense, intangible assets, 2015 861,000,000    
Estimated annual amortization expense, intangible assets, 2016 745,000,000    
Minimum amortization period, intangible assets (in years) 2    
Maximum amortization period, intangible assets (in years) 30    
Average amortization period, intangible assets (in years) 11    
Proprietary Pharmaceutical Products
     
Goodwill and intangible assets information      
Goodwill 6,200,000,000    
Established Pharmaceutical Products
     
Goodwill and intangible assets information      
Goodwill 3,000,000,000    
Nutritional Products
     
Goodwill and intangible assets information      
Goodwill 209,000,000    
Diagnostic Products
     
Goodwill and intangible assets information      
Goodwill 385,000,000    
Vascular Products
     
Goodwill and intangible assets information      
Goodwill $ 2,600,000,000